Published in Urology on July 01, 2007
Three-dimensional vision enhances task performance independently of the surgical method. Surg Endosc (2012) 1.47
Comparison of two- and three-dimensional camera systems in laparoscopic performance: a novel 3D system with one camera. Surg Endosc (2009) 1.30
A randomized prospective study comparing acquisition of laparoscopic skills in three-dimensional (3D) vs. two-dimensional (2D) laparoscopy. World J Surg (2014) 1.14
Three-dimensional versus two-dimensional vision in laparoscopy: a systematic review. Surg Endosc (2015) 1.09
Advanced stereoscopic projection technology significantly improves novice performance of minimally invasive surgical skills. Surg Endosc (2012) 1.09
Perceptual impairment and psychomotor control in virtual laparoscopic surgery. Surg Endosc (2011) 0.99
3D visualization reduces operating time when compared to high-definition 2D in laparoscopic liver resection: a case-matched study. Surg Endosc (2015) 0.95
An assessment of the new generation three-dimensional high definition laparoscopic vision system on surgical skills: a randomized prospective study. Surg Endosc (2014) 0.86
[Not Available]. J Minim Access Surg (2008) 0.86
3D vs 2D laparoscopic radical prostatectomy in organ-confined prostate cancer: comparison of operative data and pentafecta rates: a single cohort study. BMC Urol (2015) 0.85
Three-dimensional imaging improves surgical skill performance in a laparoscopic test model for both experienced and novice laparoscopic surgeons. Surg Endosc (2014) 0.85
3D Laparoscopy - Help or Hype; Initial Experience of A Tertiary Health Centre. J Clin Diagn Res (2014) 0.84
A comparative analysis of lung cancer patients treated with lobectomy via three-dimensional video-assisted thoracoscopic surgery versus two-dimensional resection. J Thorac Dis (2015) 0.75
Comparative study of three-dimensional versus two-dimensional video-assisted thoracoscopic two-port lobectomy. Thorac Cancer (2016) 0.75
Impact of Training on Three-Dimensional versus Two-Dimensional Laparoscopic Systems on Acquisition of Laparoscopic Skills in Novices: A Prospective Comparative Pilot Study. Biomed Res Int (2016) 0.75
Testicular and paratesticular tumours in the prepubertal population. Lancet Oncol (2010) 2.13
Robotic management of genitourinary injuries from obstetric and gynaecological operations: a multi-institutional report of outcomes. BJU Int (2014) 2.07
Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol (2009) 1.87
Nanotechnology: potential applications in urology. BJU Int (2006) 1.56
Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons. J Urol (2009) 1.53
Complications associated with extraperitoneal robot-assisted radical prostatectomy using the standardized Martin classification. Urology (2013) 1.44
Video-games station or minimally invasive skills training station? BJU Int (2009) 1.43
Benign prostatic hyperplasia: solutions to an ageing problem. Hosp Med (2002) 1.43
Nanotechnology and its relevance to the urologist. Eur Urol (2007) 1.38
Tissue elasticity properties as biomarkers for prostate cancer. Cancer Biomark (2008) 1.34
Quantitative characterization of viscoelastic properties of human prostate correlated with histology. Ultrasound Med Biol (2008) 1.30
Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol (2012) 1.18
Congruence of imaging estimators and mechanical measurements of viscoelastic properties of soft tissues. Ultrasound Med Biol (2007) 1.12
Part I: Primary malignant non-Wilms' renal tumours in children. Lancet Oncol (2007) 1.08
Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease. Cancer (2013) 1.08
Predicting erectile function outcome in men after radical prostatectomy for prostate cancer. BJU Int (2011) 1.05
Robotic and laparoscopic surgery: cost and training. Surg Oncol (2009) 1.03
CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes. Radiology (2002) 0.99
Impact of ureteral stent diameter on symptoms and tolerability. J Endourol (2003) 0.96
Race/ethnicity-based concerns over understanding cancer diagnosis and treatment plan. J Natl Med Assoc (2010) 0.95
Molecular and genetic pathways in penile cancer. Lancet Oncol (2007) 0.93
Impact of prostate size in robot-assisted radical prostatectomy. J Endourol (2007) 0.93
Greenlight prostatectomy: a challenge to the gold standard? A review of KTP photoselective vaporization of the prostate. Surg Laparosc Endosc Percutan Tech (2007) 0.92
Current challenges in Wilms' tumor management. Nat Clin Pract Oncol (2005) 0.92
Robot-assisted extraperitoneal radical prostatectomy in a patient with a pelvic kidney. Urology (2006) 0.91
Multispectral Photoacoustic Imaging of Prostate Cancer: Preliminary Ex-vivo Results. J Clin Imaging Sci (2013) 0.90
Robot-assisted radical prostatectomy in obese patients. Can J Urol (2006) 0.89
Renal transplantation in adults with abnormal bladders. Transplantation (2004) 0.89
Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists. BMC Urol (2007) 0.86
Ergonomic evaluation and guidelines for use of the daVinci Robot system. J Endourol (2010) 0.86
Randomized comparison of extraperitoneal and transperitoneal access for robot-assisted radical prostatectomy. J Endourol (2007) 0.86
Focal cryotherapy of localized prostate cancer: a systematic review of the literature. Expert Rev Anticancer Ther (2014) 0.85
Molecular prognostic factors in penile cancer. World J Urol (2008) 0.85
Management of detrusor-external sphincter dyssynergia. Nat Clin Pract Urol (2006) 0.82
Complications of laparoscopic urologic surgery. J Laparoendosc Adv Surg Tech A (2004) 0.82
Part II: Treatment of primary malignant non-Wilms' renal tumours in children. Lancet Oncol (2007) 0.81
The Dukes staging system: a cornerstone in the clinical management of colorectal cancer. Lancet Oncol (2009) 0.81
Targeting vascular endothelial growth factor in renal cell carcinoma. Tumour Biol (2009) 0.81
Long-term follow-up after retroperitoneal laparoscopic decortication of symptomatic renal cysts. Urol Int (2007) 0.80
Expanding role of chemokines and their receptors in cancer. Expert Rev Anticancer Ther (2003) 0.80
Patient-reported validated functional outcome after extraperitoneal robotic-assisted nerve-sparing radical prostatectomy. JSLS (2008) 0.80
The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics. Expert Opin Pharmacother (2006) 0.79
Nanotechnology in the management of prostate cancer. BJU Int (2008) 0.79
Tissue microarrays and their relevance to the urologist. J Urol (2006) 0.78
Erectile dysfunction. BMJ (2014) 0.78
Robotic-assisted abdominoperineal resection with obturator lymph node dissection: a multidisciplinary approach. Dis Colon Rectum (2014) 0.77
Testicular cancer: current update and controversies. Hosp Med (2002) 0.77
Is there a role for cardiopulmonary exercise testing before major urological surgery. BJU Int (2009) 0.77
Peyronie's disease: an update of the medical management. Expert Opin Pharmacother (2004) 0.77
Analysis of a large single-center experience with robot-assisted pyeloplasty. Int J Urol (2012) 0.77
Tissue microarrays. Expert Rev Mol Diagn (2004) 0.77
Current status of robotic surgery in pediatric urology. Pediatr Surg Int (2008) 0.76
Priapism--a review of the medical management. Expert Opin Pharmacother (2003) 0.76
Intraluminal robotics: a new dawn in minimally invasive surgery? BJU Int (2008) 0.76
Luteinising hormone releasing hormone analogues in the treatment of prostate cancer. Expert Opin Pharmacother (2002) 0.76
A training model for suprapubic catheter insertion: the UroEmerge suprapubic catheter model. Urology (2008) 0.76
New phosphodiesterase inhibitors in the treatment of erectile dysfunction. Expert Opin Pharmacother (2004) 0.76
Natural orifice transluminal endoscopic surgery: a new dimension in minimally invasive surgery. Expert Rev Gastroenterol Hepatol (2008) 0.76
Evaluation and management of post-shock wave lithotripsy pain with third-generation lithotriptors using rofecoxib. J Endourol (2009) 0.76
Technological aspects of delivering cryotherapy for prostate cancer. Expert Rev Med Devices (2015) 0.76
Role of frozen section analysis of surgical margins during robot-assisted laparoscopic radical prostatectomy: a 2608-case experience. Hum Pathol (2013) 0.76
Epistaxis after sildenafil. J R Soc Med (2002) 0.75
Robot-assisted laparoscopic adrenalectomy: preliminary UK results. BJU Int (2004) 0.75
Authors' reply to Bunker. BMJ (2013) 0.75
Re: transperitoneal or extraperitoneal approach for laparoscopic radical prostatectomy: a false debate over a real challenge. J Urol (2004) 0.75
Re: The pharmacological management of intermittent priapismic states. BJU Int (2009) 0.75
Management of testicular torsion. J R Soc Med (2002) 0.75
Re: Lasser et al.: An unbiased prospective report of perioperative complications of robot-assisted laparoscopic radical prostatectomy (Urology 2010;75:1083-1091). Urology (2011) 0.75
Patient-reported validated functional outcome after extraperitoneal robotic-assisted nerve-sparing radical prostatectomy. JSLS (2007) 0.75
Modifications to facilitate extraperitoneal robot-assisted radical prostatectomy post kidney transplant. JSLS (2013) 0.75
Endoscopic ablation: Irreversible tide of technological advancement? BMJ (2008) 0.75
Anti-emetic therapy: updating urological cancer-care providers. BJU Int (2006) 0.75
Salvage laparoscopic surgery in advanced prostate cancer: is it possible or beneficial? Expert Rev Anticancer Ther (2008) 0.75
Laparoscopic cryotherapy for renal tumours. BJU Int (2012) 0.75
Vasectomy illustrated. BJU Int (2012) 0.75
Three-dimensional visualization in laparoscopic surgery. BJU Int (2006) 0.75
Nano- and microrobotics: how far is the reality? Expert Rev Anticancer Ther (2008) 0.75
The overactive bladder: review of current pharmacotherapy in adults. Part 1: pathophysiology and anticholinergic therapy. Expert Opin Pharmacother (2006) 0.75
Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets. Expert Rev Anticancer Ther (2005) 0.75
Molecular markers in penile cancer. Curr Probl Cancer (2015) 0.75
Robotic versus nonrobotic surgery: experts, toys and prostatectomy. Expert Rev Anticancer Ther (2008) 0.75
Bladder cancer: a current update. Hosp Med (2003) 0.75
Alternative use of botulinum toxin in urology. Expert Opin Pharmacother (2004) 0.75
Photodynamic diagnostic cystoscopy. BJU Int (2012) 0.75
Factors associated with ureteral burn injury from an electrified guidewire. J Endourol (2008) 0.75
Key papers in prostate cancer. Expert Rev Anticancer Ther (2014) 0.75
Radiommunotherapy and prostate cancer: a promising new therapy in the management of metastatic disease. BJU Int (2006) 0.75
Is there a proper pelvic size for an extraperitoneal robot-assisted radical prostatectomy? J Endourol (2007) 0.75
Robotic surgery: the coming of a new era in surgical innovation. Expert Rev Anticancer Ther (2005) 0.75
The ligated ureter: beware or be aware. Br J Hosp Med (Lond) (2006) 0.75
Expanding role of nanotechnology in the management of colorectal cancer. Expert Rev Anticancer Ther (2009) 0.75
Molecular therapeutic targets for bladder cancer. Expert Rev Anticancer Ther (2007) 0.75
Allogeneic stem-cell transplantation for renal-cell cancer. Lancet Oncol (2004) 0.75
Current concepts in the pharmacotherapy of benign prostatic hyperplasia. Expert Opin Pharmacother (2002) 0.75